JP Patent

JP5572154B2 — テトラヒドロキノリン化合物を有効成分とする貧血の予防及び／又は治療剤

Assigned to Kowa Co Ltd · Expires 2014-08-13 · 12y expired

What this patent protects

Patent listed against Opsumit.

Drugs covered by this patent

Patent Metadata

Patent number
JP5572154B2
Jurisdiction
JP
Classification
—
Expires
2014-08-13
Drug substance claim
No
Drug product claim
No
Assignee
Kowa Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.